Hirohito Kubota

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Binding Protein

Top Venues

Pediatric blood & cancer

Molecules and cells

This page only lists publications with an associated author ORCID identifier.

Publications

Kiyotaka Isobe, Satoshi Saida, Yoshitaka Honda, Hiroshi Nihira, Eitaro Hiejima, Kazushi Izawa, Hirohito Kubota, Itaru Kato, Katsutsugu Umeda, Hidefumi Hiramatsu, Takahiro Yasumi, Junko Takita
Successful cord blood transplantation using reduced intensity conditioning in a 5-month-old patient with IL-10RA deficiency. Pediatric blood & cancer 71 (8) (2024)
Kiyotaka Isobe, Satoshi Saida, Yoshitaka Honda, Hiroshi Nihira, Eitaro Hiejima, Kazushi Izawa, Hirohito Kubota, Itaru Kato, Katsutsugu Umeda, Hidefumi Hiramatsu, Takahiro Yasumi, Junko Takita
Successful cord blood transplantation using reduced intensity conditioning in a 5-month-old patient with IL-10RA deficiency. Pediatric blood & cancer (2024)
Kiyotaka Isobe, Satoshi Saida, Yoshitaka Honda, Hiroshi Nihira, Eitaro Hiejima, Kazushi Izawa, Hirohito Kubota, Itaru Kato, Katsutsugu Umeda, Hidefumi Hiramatsu, Takahiro Yasumi, Junko Takita
Successful cord blood transplantation using reduced intensity conditioning in a 5-month-old patient with IL-10RA deficiency. Pediatric blood & cancer 71 (8) (2024)
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, Nobuyuki Kakiuchi, Yasuhito Nannya, Seishi Ogawa, Hidefumi Hiramatsu, Junko Takita
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood advances 8 (5) (2024)
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, Nobuyuki Kakiuchi, Yasuhito Nannya, Seishi Ogawa, Hidefumi Hiramatsu, Junko Takita
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood advances 8 (5) (2024)
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, Nobuyuki Kakiuchi, Yasuhito Nannya, Seishi Ogawa, Hidefumi Hiramatsu, Junko Takita
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood advances (2023)
Hirokazu Kobushi, Satoshi Saida, Katsutsugu Umeda, Atsushi Iwai, Kagehiro Kozuki, Hirohito Kubota, Kuniaki Tanaka, Satoshi Obu, Yoshinori Uchihara, Keiji Tasaka, Itaru Kato, Hidefumi Hiramatsu, Junko Takita
High-dose carboplatin-irinotecan-temozolomide is an effective salvage chemotherapy for relapsed or refractory neuroblastoma. Pediatric blood & cancer (2023)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Koji Nakajima, Hirohito Kubota, Itaru Kato, Kiyotaka Isobe, Hiroo Ueno, Kagehiro Kozuki, Kuniaki Tanaka, Naoko Kawabata, Takashi Mikami, Kosuke Tamefusa, Ritsuo Nishiuchi, Satoshi Saida, Katsutsugu Umeda, Hidefumi Hiramatsu, Souichi Adachi, Junko Takita
PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch. Cancer science 113 (7) (2022)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Naoko Kawabata, Hidefumi Hiramatsu, Takashi Mikami, Ryo Akazawa, Kuniaki Tanaka, Kagehiro Kouzuki, Hirohito Kubota, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Tomoaki Hirate, Kaori Kanda, Souichi Adachi, Junko Takita
Chimeric antigen receptor T-cell therapy for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia and leukoencephalopathy who relapsed after bone marrow transplantation. Pediatric blood & cancer 69 (11) (2022)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)